UltiMed, Inc. develops products for International markets
- October 5, 2009
- Corporate News
St. Paul, MN – October 5, 2009 – UltiMed, Inc. announces the introduction of a yellow UltiGuard™ package style for distribution in international markets at the Canadian Diabetes Association Professional Conference in Montreal. The unique and exclusive UltiGuard package style combines premium quality needles and an approved sharps container all in one system. The introduction of a yellow UltiGuard meets the sharps compliance standards for Canada and Europe.
UltiMed, Inc., headquartered in St. Paul, Minnesota, manufactures diabetic drug delivery and specialty safety syringe devices, including insulin syringes, pen needles and specialty safety syringes for both the domestic and international markets. The company owns and operates two state of the art medical device-manufacturing facilities in the U.S. and abroad. UltiMed, Inc. has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world. UltiMed, Inc. is a leader in safe needle disposal, and offers their full-line of diabetic insulin syringes and pen needles in a patented UltiGuard™ dual- use packaging style. The exclusive packaging style combines premium quality needles and an approved sharps container all in one system.